FGL1:LAG3 TR-FRET Assay Kit

Only %1 left
Catalog #
79739
As low as $790 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The FGL1:LAG3 TR-FRET Assay is designed to measure the inhibition of LAG3 binding to FGL1 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; a sample containing biotinylated LAG3, His-tagged FGL1 protein, and an inhibitor are incubated for one hour. Then, anti-His Tb donor and dye-labeled acceptor are added and fluorescence intensity is measured using a fluorescence reader.

Need us to run inhibitor screens or profile your compounds against FGL1:LAG3? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
HFREP1, HP-041, LFIRE-1, LFIRE1, fibrinogen like 1
Product Info
Storage and Usage
Citations
Assay Kit Format
TR-FRET
Materials Required But Not Supplied

Fluroescence microplate reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET)
Adjustable micropipettor and sterile tips

Format
96 Reactions:
 

Catalog
Number


Component


Amount


Storage

100330

FGL1, His tag

5 µg

-80°C





Avoid

multiple
freeze/thaw
cycles!

71147

LAG3 (CD223), Biotin-labeled (Human) HiP™

10 µg

-80°C

30017

Anti-His Tb Donor

2 x 10 µl

-20°C

 

Dye-labeled Acceptor

2 x 10 µl

-20°C

 

3x FGL1 TR-FRET Buffer

4 ml

-20°C

79696

White, 96-well microtiter plate

1

Room. temp

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

384 Reactions:

Catalog
Number


Component


Amount


Storage

100330

FGL1, His tag

2 x 5 µg

-80°C






Avoid

multiple
freeze/thaw
cycles!

71147

LAG3 (CD223), Biotin-labeled (Human) HiP™

2 x 10 µg

-80°C

30017

Anti-His Tb Donor

2 x 10 µl

-20°C

 

Dye-labeled Acceptor

2 x 10 µl

-20°C

 

3x FGL1 TR-FRET Buffer

4 ml

-20°C

 

White, 384-well microtiter plate

1

Room. temp

Background
Lymphocyte-activation gene 3 (LAG3, also CD223) is a cell surface receptor that negatively regulates activation and proliferation of T cells. Fibrinogen-like protein 1 (FGL1), a liver-secreted protein, is a functional LAG3 ligand. Blockade of the FGL1-LAG3 interaction is implicated in promoting antitumor immunity.
References

1. Wang, J., et al. Cell 2019, 176(1-2): 334-347
2. Visan. I., et al. Nature Immunol. 2019, 20(2): 111